Youth mHealth Adherence Intervention for HIV+ YMSM

Completed · Not applicable

Conditions studied: HIV

In brief

This study will help determine feasibility, acceptability, and preliminary efficacy of an app for HIV medication adherence over a 3-month period. Participation is 3 months consisting of two study visits: An initial study visit and a 3 month follow up visit with both visits lasting about 60-90 minutes. The participant must use the study application (app) at least once daily, and at study visits, must complete surveys.

Key facts

Study ID

NCT03092115

Run by

Children's Hospital of Philadelphia

People needed

6

Starts

2017-05-22

Expected to finish

2019-05-31

Last updated by the study team

2019-09-04

Who can join

Age: 14 and older, up to 24. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Males (sex at birth male) age 14 to 24 years.
• HIV-positive
• Owns an Android smart phone
• Within 1-month of initiating antiretroviral therapy (ART) medication, previously failed ART and about to restart an ART regimen, or currently on ART having trouble with adherence (defined as having a detectable viral load above 200 copies/ml).
• MSM (men who have sex with men)
• Receiving care at the Children's Hospital of Philadelphia (CHOP) Adolescent HIV clinic at the time of the study

You may not qualify if…

• Females (sex at birth; not gender)
• Males age 13 years or younger or 25 years and older.
• HIV-negative or status unknown
• Not in care at the CHOP Adolescent HIV clinic at the time of the study.
• Does not own an Android smart phone (iPhone, Blackberry, etc. phone users)
• Is already ART adherent (defined as having an undetectable or suppressed, <200 copies/ml, viral load) or is not on or going to be on ART during the study period.

Where it is running

• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.